Sorrento Tech (ROKA) Earning Somewhat Critical News Coverage, Report Finds

News stories about Sorrento Tech (NASDAQ:ROKA) have been trending somewhat negative on Tuesday, Accern Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Sorrento Tech earned a daily sentiment score of 0.00 on Accern’s scale. Accern also assigned media headlines about the medical research company an impact score of 45.6942797364516 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

Shares of Sorrento Tech (ROKA) opened at $0.66 on Tuesday. Sorrento Tech has a twelve month low of $0.60 and a twelve month high of $6.20. The firm has a market capitalization of $3.32, a PE ratio of -0.07 and a beta of 2.23.

In other Sorrento Tech news, major shareholder Orbimed Advisors Llc sold 127,601 shares of Sorrento Tech stock in a transaction dated Wednesday, September 27th. The stock was sold at an average price of $0.98, for a total transaction of $125,048.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold a total of 803,894 shares of company stock valued at $603,915 in the last ninety days. Insiders own 29.20% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Sorrento Tech (ROKA) Earning Somewhat Critical News Coverage, Report Finds” was published by Week Herald and is owned by of Week Herald. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at

About Sorrento Tech

Sorrento Tech, Inc, formerly Roka Bioscience, Inc, is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

Insider Buying and Selling by Quarter for Sorrento Tech (NASDAQ:ROKA)

Receive News & Ratings for Sorrento Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Tech and related companies with's FREE daily email newsletter.

Leave a Reply